MANNKIND CORP (MNKD:NASDAQ)
$3.29 -0.13 (-3.8012%)
Analysed MANNKIND CORP (MNKD:NASDAQ) News Sources
MannKind (MNKD) Reports Q2 Loss, Beats Revenue Estimates
05-08-2026
yahoo.com
Compared to Estimates, MannKind (MNKD) Q2 Earnings: A Look at Key Metrics
05-08-2026
yahoo.com
MannKind Q2 Earnings Call Highlights
06-08-2026
marketbeat.com
MannKind's Diversified Portfolio Seen Leading to Higher Revenue in H2, Wedbush Says
06-08-2026
yahoo.com
MannKind (MNKD) Could Be 48% Undervalued Following Its Afrezza And Pipeline Narrative
29-08-2026
yahoo.com
MannKind to Present at Upcoming Investor Conferences
02-09-2026
yahoo.com
MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management
09-09-2026
yahoo.com
MannKind Expands Into Weight Loss With Rose Pharma Deal – Here’s What Investors Are Watching
09-09-2026
stocktwits.com
MannKind (MNKD) Bets On Inhaled Weight Loss Amid Widening Losses
16-09-2026
yahoo.com
MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)
10-10-2026
yahoo.com
What is the current price of MANNKIND CORP (MNKD:NASDAQ)?
The current price of MANNKIND CORP (MNKD:NASDAQ) is $3.29.
MANNKIND CORP (MNKD:NASDAQ) absolute price change since previous trading day?
The absolute price change of MANNKIND CORP (MNKD:NASDAQ) since the previous trading day is $-0.13.
MANNKIND CORP (MNKD:NASDAQ) percentage price change since previous trading day?
The percentage price change of MANNKIND CORP (MNKD:NASDAQ) since the previous trading day is -3.8012%.
What is the most recent average sentiment score for MANNKIND CORP (MNKD:NASDAQ)?
The most recent average sentiment score for MANNKIND CORP (MNKD:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for MANNKIND CORP (MNKD:NASDAQ)?
The most recent sentiment for MANNKIND CORP (MNKD:NASDAQ) is .
SEC-8K** Filing Available For MANNKIND CORP (MNKD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.